GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » Shiller PE Ratio

Incannex Healthcare (STU:IQI) Shiller PE Ratio : (As of May. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Incannex Healthcare Shiller PE Ratio Historical Data

The historical data trend for Incannex Healthcare's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Shiller PE Ratio Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Incannex Healthcare's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incannex Healthcare's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's Shiller PE Ratio falls into.



Incannex Healthcare Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Incannex Healthcare's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Incannex Healthcare's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/127.6062*127.6062
=0.000

Current CPI (Mar. 2024) = 127.6062.

Incannex Healthcare Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.268 98.352 -0.348
201409 0.000 98.816 0.000
201412 -0.009 99.002 -0.012
201503 0.000 99.187 0.000
201506 -0.037 99.838 -0.047
201509 0.000 100.302 0.000
201512 -0.005 100.673 -0.006
201603 0.000 100.488 0.000
201606 -0.005 100.859 -0.006
201609 0.000 101.602 0.000
201612 -0.191 102.159 -0.239
201703 0.000 102.624 0.000
201706 0.050 102.809 0.062
201709 0.000 103.460 0.000
201712 -0.005 104.110 -0.006
201803 0.000 104.574 0.000
201806 -0.005 104.945 -0.006
201809 0.000 105.410 0.000
201812 -0.003 105.967 -0.004
201903 0.000 105.967 0.000
201906 -0.002 106.617 -0.002
201909 0.000 107.174 0.000
201912 -0.003 107.917 -0.004
202003 0.000 108.289 0.000
202006 -0.003 106.246 -0.004
202009 0.000 107.917 0.000
202012 -0.003 108.846 -0.004
202103 0.000 109.496 0.000
202106 -0.959 110.332 -1.109
202109 0.000 111.168 0.000
202112 -0.004 112.654 -0.005
202203 0.000 115.069 0.000
202206 -1.178 117.112 -1.284
202209 0.000 119.248 0.000
202212 -0.006 121.477 -0.006
202303 0.000 123.148 0.000
202306 -0.006 124.170 -0.006
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000
202403 0.000 127.606 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Incannex Healthcare  (STU:IQI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Incannex Healthcare Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare (STU:IQI) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.